04:53 PM EDT, 06/04/2026 (MT Newswires) -- William Guyer, Chief Development Officer, on June 02, 2026, sold 20,000 shares in Corcept Therapeutics ( CORT ) for $1,412,000. Following the Form 4 filing with the SEC, Guyer has control over a total of 3,985 common shares of the company, with 3,985 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1088856/000119312526257618/xslF345X05/ownership.xml